Priority Date: 11.08.14 (US 201462070016P)

MODIFIED IL-2 VARIANTS THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

  • Application ID: EP15831523
  • Status: The patent has been granted

Attorney

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Carpmaels & Ransford LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 228 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 11.08.2014 - Priority Date (US 201462070016P)
  • 18.02.2016 - Publication A1 (WO2016025385)
  • 21.06.2017 - Publication A1 (EP3180020)
  • 26.12.2018 - Publication B1 (EP3180020)

IPC Classification